Consequently, HERC5-mediated NLRP3 ISGylation in humans and HERC6-mediated ISGylation in mice enhances NLRP3 inflammasome activation, whereas HERC6 deficiency mitigates the NLRP3-dependent inflammation-related pathologies induced by viral infection [238]. This evidence concerns the gene HERC6 and viral infectious disease.